Key Developments
Swire Pacific Ltd (00019/00087) has successfully executed an accelerated share exchange transaction, fast-tracking the conversion process for its HK$4.7 billion Cathay Pacific exchangeable bonds.
Nations Technologies Inc (02701) plans to invest in Nanjing Youcun Technology to strengthen its NOR Flash external storage MCU customization capabilities.
Hua Hong Semiconductor Ltd (01347) has entered into a joint venture investment agreement and a joint venture shareholders' agreement, aiming to boost its competitiveness and market position in the global and mainland China wafer foundry sectors.
CSSC (Hong Kong) Shipping Co Ltd (03877) intends to spend RMB 3.235 billion to build ten vessels.
Zhaogang Network-W (06676) has launched NextB2B, an AI Agent solution for the trade industry.
Tencent Music Entertainment Group-SW (01698) plans to offer senior unsecured notes for public sale.
Simeere Pharmaceutical Group (02096) has signed an exclusive licensing agreement with Roche for SIM0660.
CSPC Pharmaceutical Group (01093) has received another Breakthrough Therapy Designation from China's National Medical Products Administration for SYS6010, this time for treating patients with recurrent or metastatic head and neck squamous cell carcinoma. Additionally, the Phase I clinical trial for SYH2056 tablets, targeting depression, has officially commenced in China.
Ocumension Therapeutics-B (01477) has received acceptance of its drug registration application for a domestically produced dexamethasone ophthalmic suspension injection.
Bravo Forms Inc (00933) has made a further acquisition of 29.6195 million shares in Li Ning Company Ltd.
Buybacks and Stake Changes
Zhongji Innolight (03308) spent RMB 318 million on September 1 to repurchase 374,100 A-shares. Li Auto Inc-W (02015) used HK$51.5173 million on the same day to buy back 1.0915 million shares. Sino Biopharmaceutical Ltd (01177) allocated HK$47.4255 million to repurchase 9 million shares. SF Holding (06936) invested HK$30.9388 million to buy back 998,200 shares. Kangfu Medical (01187) spent RMB 28.4343 million to repurchase 574,000 A-shares. J&T Express-W (01519) used approximately HK$15.6805 million to repurchase 1.62 million shares.
Operational Results
With all three brands achieving simultaneous growth in volume and price, NIO Inc-SW (09866) reported second-quarter total revenues of RMB 32.1369 billion, marking a 69.1% year-on-year increase and a 25.9% quarter-on-quarter rise.
BYD Co Ltd (01211) sold approximately 440,300 vehicles in August, up 17.84% year-on-year. Geely Automobile Holdings Ltd (00175)'s total vehicle sales for August reached 270,194 units, representing an approximately 8% year-on-year increase. Great Wall Motor Co Ltd (02333) posted total August sales of roughly 113,400 units, down 1.87% from a year earlier. Seres Group Co Ltd (09927) produced around 26,500 vehicles and sold approximately 27,700 units in August. Chery Automobile Co Ltd (09973) reported a combined total of 262,990 vehicles sold across its five major brands in August, an increase of about 14.0% year-on-year. Voyah Automobile (07489) delivered approximately 102,500 new vehicles in the first eight months of the year, up 25% year-on-year.
Sino Land Co Ltd (00083) has released its annual results, with shareholders' attributable profit reaching HK$4.589 billion, representing a 14.18% increase year-on-year. Sunny Side Up Culture Holdings Ltd (01686) also announced full-year results, posting shareholders' attributable profit of HK$1.146 billion, up 16.96% year-on-year.
Risk Warnings
The Securities and Futures Commission of Hong Kong has flagged that the shareholding of Pujiang China Group Ltd (01417) is highly concentrated. In response, Pujiang China (01417) stated that it has maintained sufficient public float.